Market Research Logo

Belarus Pharmaceuticals and Healthcare Report Q2 2015


Attention: There is an updated edition available for this report.

Belarus Pharmaceuticals and Healthcare Report Q2 2015

BMI View: The volatility of the Belarusian rouble and high inflation will hurt consumer incomes and therefore the growth outlook of the pharmaceutical market over the next two years. Furthermore, increased scrutiny by President Lukashenko over pharmaceutical imports indicates that Belarus may follow neighbouring Russia in instituting measures that favour the domestic industry and restrict the market for pharmaceutical imports.

Headline Expenditure Projections

Pharmaceuticals: BYR10,223bn in 2014 (USD998mn) to BYR12,101bn (USD869mn) in 2015; +18.4% in local currency terms and -12.9% in US dollar terms.

Healthcare: BYR36,100bn (USD3.50bn) in 2013 to BYR42,419bn (USD3.05bn) in 2015; +17.5% in local currency terms and -13.5% in US dollar terms.


BMI Industry View
SWOT
Political
Economic
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2011-2019)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2011-2019)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2011-2019)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2011-2019)
Key Risks To BMI's Forecast Scenario
Macroeconomic Forecasts
Economic Analysis
Table: GDP Contribution To Growth (Belarus 2011-2019)
Industry Risk Reward Ratings
Central And Eastern Europe Risk/Reward Index
Belarus Risk/Reward Index
Rewards
Risks
Market Overview
Industry Trends And Developments
Epidemiology
Healthcare Sector
Healthcare Provision
Healthcare Sector Reforms
Healthcare Insurance
Table: Healthcare Resources
Table: Healthcare Activity
Table: Healthcare Personnel
Medical Tourism
Research And Development
Clinical Trials
Regulatory Development
Recent Regulatory Developments
Customs Union
Pharmaceutical Advertising
Intellectual Property Rights
Counterfeit Drugs
Pricing And Reimbursement
Recent Pricing & Reimbursement Developments
Tendering Procedures
Competitive Landscape
Pharmaceutical Sector
Generic Drugmakers
Research-Based Industry
Recent Pharmaceutical Sector Developments
Pharmaceutical Wholesale And Retail
Company Profile
Belbiopharm
Lekpharm
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Belarus 1990-2025)
Table: Key Population Ratios (Belarus 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Belarus 1990-2025)
Table: Population By Age Group (Belarus 1990-2025)
Table: Population By Age Group % (Belarus 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report